MorningMed is a community of 814,300 medical professionals

We're a place where medical professionals share news and other news items to help their peers stay up to date

All articles tagged: Anorexia (R63.0)

HealthDay 11 July at 12.43 PM

New Research Points Towards Potential Treatment for Anorexia

Anorexia nervosa could be caused by lack of a specific brain chemical, reports a research team that has developed a possible cure for the eating disorder.Mouse studies have revealed that a deficit in acetylcholine, a neurotra

HealthDay 14 June at 08.51 PM

FDA Approves Generic Emflaza Oral Suspension for Duchenne Muscular Dystrophy

The U.S. Food and Drug Administration has approved the first generic version of Emflaza (deflazacort) oral suspension for Duchenne muscular dystrophy (DMD).Deflazacort oral suspension is a corticosteroid indicated to treat DMD in patients 5 years of age and older but is contraindicated in patients with known hypersensitivity to deflazacort. The

HealthDay 17 January at 05.10 PM

FDA Approves Casgevy to Treat Beta-Thalassemia

After approving Casgevy (exagamglogene autotemcel) in December to treat sickle cell disease, the U.S. Food and Drug Administration announced Tuesday that the therapy has now been approved to treat patients older than 12 years with transfusion-dependent beta-thalassemia.Casgevy is the first CRIS

HealthDay 16 January at 11.45 PM

FDA Says Marijuana Should Be Reclassified as Less Risky Drug

Citing research that revealed marijuana has less potential for abuse than other drugs with the same restrictions, scientists from the U.S. Food and Drug Administration say it should be reclassified as a less dangerous drug.Right now, cannabis is classified as a Schedule I contro